HTG Molecular Diagnostics Inc Shares Close the Day 18.1% Higher - Daily Wrap
The company saw its shares close the day 18.1% higher than yesterday, with trading volume higher than its 30 day average.
Dec 26, 2021 by Kwhen Finance Editors
HTG Molecular Diagnostics Inc (HTGM) shares closed today 18.1% higher than it did at the end of yesterday. The stock is currently down 8.8% year-to-date, down 10.3% over the past 12 months, and down 84.7% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%.
Trading Activity
- Shares traded as high as $4.50 and as low as $3.19 this week.
- Shares closed 45.0% below its 52-week high and 37.0% above its 52-week low.
- Trading volume this week was 67.7% lower than the 10-day average and 52.1% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| HTG Molecular Diagnostics Inc | 18.1 | -8.8 | -10.3 | -53.6 | 15.7 |
| Dow Jones Industrial Average | 0.6 | 19.5 | 21.0 | -1.6 | 22.0 |
| S&P 500 Index | 0.6 | 27.5 | 29.2 | -0.7 | 30.2 |
| Health Care | 0.5 | 22.4 | 24.0 | -0.3 | 26.5 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -69.8%
- The company's stock price performance over the past 12 months beats the peer average by -68.5%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| HTG Molecular Diagnostics Inc | HTGM | 0 | -8.8 | -10.3 | -53.6 | 15.7 |
| Peer Avg | N/A | -3.5 | -29.1 | -32.6 | -67.1 | 15.3 |
| Lexicon Pharmaceuticals Inc | LXRX | -9.6 | 27.5 | 24.9 | -56.5 | 32.1 |
| Affimed N.V. | AFMD | 0 | 1.5 | -8.5 | -51.5 | 19.0 |
| Radius Health Inc. | RDUS | -4.4 | -60.0 | -61.0 | -73.2 | 6.2 |
| Calithera Biosciences Inc | CALA | 0 | -85.3 | -85.9 | -87.0 | 3.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: